Last reviewed · How we verify

NCT04355559

The Value of Diaphragmatic Ultrasound in Non-invasive Oxygen Therapy

Status unknown Last updated 21 April 2020
What this trial tests

trial in Diaphragm Ultrasound in 120 participants. Status unknown.

Timeline
1 August 2018
Primary endpoint
30 April 2020
31 August 2020

Quick facts

Lead sponsorChinese PLA General Hospital
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment120
Start date1 August 2018
Primary completion30 April 2020
Estimated completion31 August 2020
Sites1 location across China

Conditions studied

Sponsor

Chinese PLA General Hospital

Who can join

18 and older, any sex, with Diaphragm Ultrasound or Intensive Care Unit. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study, a single-center, prospective, observational study was adopted to set the cut-off values of diaphragmatic ultrasound results and arterial blood gas results,with the choice of non-invasive oxygen therapy as the gold standard,so as to evaluate the diagnostic value of diaphragmatic ultrasound in the selection of non-invasive oxygen therapy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Chinese PLA General Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04355559.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing